Telesis Bio (TBIO) Price-to-Projected Revenue Ratio
Telesis Bio, Inc. (TBIO) generates revenue through the sale of DNA synthesis systems, creating customer dependency on consumables. Stable plant operations and the implementation of ESG standards support the trend of the company's expected P/S on the GURU.Markets chart. The current movement of this indicator confirms the market consensus, while 0.30 expresses the metric's value today, helping to assess the fair value of the asset for a potential acquisition.
Telesis Bio, Inc - analytical breakdowns and key metrics (TBIO)
The long-term sustainability of Telesis Bio, Inc. (TBIO) is determined by the market's ability to capitalize expected cash flows, as reflected by this forward revenue multiple. This indicator compares the current share price with future earnings, allowing investors to assess whether the asset is overvalued between reporting periods, particularly in the context of the commercialization of BioXp systems and growth in sales of consumables for DNA and mRNA synthesis.
